Viatris reported $3.03B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Celltrion KRW 1.51T 128.69B Sep/2025
Cspc Pharmaceutical CNY 8.85B 769.12M Jun/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 5M 4.96M Sep/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Kangmei Pharma CNY 3.15B 295.48M Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.65M 162K Jun/2025
Neuren Pharmaceuticals AUD 20.71M 155.01M Jun/2025
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Ovoca Bio EUR 447K 113K Jun/2022
Pharma Mar EUR 41.76M 26.1M Sep/2025
Qiagen NV USD 402.61M 9.05M Dec/2025
Sartorius EUR 344.7M 48.5M Sep/2025
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 121.49M 18.12M Mar/2025
Viatris USD 3.03B 340.3M Dec/2025
Zz Pientze Pharmaceu CNY 1.12B 222.78M Sep/2025